CAS 167354-91-8

(+/-)-13-Hydroxy-9Z,11E-octadecadienoic acid,cholesterylester (9Z,11E)-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) 13-hydroxyoctadeca-9,11-dienoate 167354-91-8

纯度 97%+现货药物标准品
CAS 号167354-91-8
分子式C45H76O3
分子量665.08 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(+/-)-13-Hydroxy-9Z,11E-octadecadienoic acid,cholesterylester (9Z,11E)-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) 13-hydroxyoctadeca-9,11-dienoate 167354-91-8 CAS 167354-91-8 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（(+/-)-13-Hydroxy-9Z,11E-octadecadienoic acid,cholesterylester (9Z,11E)-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) 13-hydroxyoctadeca-9,11-dienoate 167354-91-8）为药物标准品，CAS 登记号 167354-91-8，分子式 C45H76O3，分子量 665.08。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

与同类药物标准品相比，的分子量为665.08 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 化学式为 C45H76O3 的（(+/-)-13-Hydroxy-9Z,11E-octadecadienoic acid,cholesterylester (9Z,11E)-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopentaaphenanthren-3-yl) 13-hydroxyoctadeca-9,11-dienoate 167354-91-8），其CAS登记号是 167354-91-8，分子量为 665.08 g/mol。 （分子式 C45H76O3）的化学结构中包含羧酸类，含羟基，含醚键，多环芳烃。在反相色谱体系中，其保留行为主要受其较高的疏水性（logP）影响，这为HPLC-UV/DAD或LC-MS方法的建立提供了重要依据。由于结构中存

应用场景：（(+/-)-13-Hydroxy-9Z,11E-octadecadienoic acid,cholesterylester (9Z,11E)-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta a phenanthren-3-yl) 13-hydroxyoctadeca-9,11-dienoate 167354-91-8）作为药物标准品，在化学分析分析领域承担着重要的角色。

理化性质 Physical & Chemical Properties

中文名称
分子式C45H76O3
分子量665.08 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）8.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2004年

相关专利 Related Patents

  1. 发明人刘建华，张德明，马晓峰. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 117079612 A, 授权公告日 2015-12-25.
  2. Park J H, Brown S R, Patel M V. "Method for the Synthesis of (+/-)-13-Hydroxy-9Z,11E-octadecadienoic acid,cholesterylester (9Z,11E)-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) 13-hydroxyoctadeca-9,11-dienoate 167354-91-8" [P]. US Patent, US 9466501 B2, 2025-04-20.

参考文献 Literature

  1. Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2023, 2312, 7097-7111.
  2. Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2022, 1901, (9), 8774-8792.
  3. Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of (+/-)-13-Hydroxy-9Z,11E-octadecadienoic acid,cholesterylester (9Z,11E)-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) 13-hydroxyoctadeca-9,11-dienoate 167354-91-8 Using HRMS and NMR". Anal. Methods, 2010, 1430, 6420-6445.

Related Hydroxy Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...